BNOEF
Price:
$0.006
Market Cap:
$23.62M
Bionomics Limited, an Australian clinical-stage biopharmaceutical company founded in 1996 and based in Eastwood, focuses on identifying and developing innovative drug candidates to address central nervous system conditions and various cancers. A significant experimental medicine in their pipeline is BNC210, a negative allosteric modulator targeting the a7 nicotinic acetylcholine receptor. This compound is currently undergoing a Phase 2 clinical trial for social anxiety disorder and a Phase 2b study for post-traumatic stress disorder (PTSD). The company's portfolio also includes BNC101, a monoclonal antibody designed to combat cancer stem cells, which has successfully completed its Phase 1 cl...[Read more]
Industry
Biotechnology
IPO Date
2014-06-24
Stock Exchange
OTC
Ticker
BNOEF
According to Bionomics Limited’s latest financial reports and current stock price. The company's current ROE is -109.66%. This represents a change of 168.18% compared to the average of -40.89% of the last 4 quarters.
The mean historical ROE of Bionomics Limited over the last ten years is -74.19%. The current -109.66% ROE has changed 47.81% with respect to the historical average. Over the past ten years (40 quarters), BNOEF's ROE was at its highest in in the March 2025 quarter at 72.35%. The ROE was at its lowest in in the September 2025 quarter at -119.80%.
Average
-74.19%
Median
-55.10%
Minimum
-219.65%
Maximum
-1.28%
Discovering the peaks and valleys of Bionomics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 786.61%
Maximum Annual ROE = -1.28%
Minimum Annual Increase = -99.03%
Minimum Annual ROE = -219.65%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1.28% | -99.03% |
| 2024 | -132.61% | -39.63% |
| 2023 | -219.65% | 295.25% |
| 2022 | -55.57% | 204.14% |
| 2021 | -18.27% | -67.45% |
| 2020 | -56.13% | 2.74% |
| 2019 | -54.63% | -63.07% |
| 2018 | -147.93% | 786.61% |
| 2017 | -16.68% | -57.37% |
| 2016 | -39.14% | -26.18% |
The current ROE of Bionomics Limited (BNOEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-117.85%
5-year avg
-85.48%
10-year avg
-74.19%
Bionomics Limited’s ROE is greater than Tetra Bio-Pharma Inc. (-467.81%), less than Immune Therapeutics, Inc. (67.11%), greater than Polydex Pharmaceuticals Limited (-53.04%), greater than HealthBeacon plc (-56.54%), less than MDxHealth S.A. (402.97%), less than Forward Pharma A/S (0.12%), less than Poxel S.A. (22.71%), greater than Eiger BioPharmaceuticals, Inc. (-367.00%), less than The Flowr Corporation (0%), greater than Living Cell Technologies Limited (-61.85%),
| Company | ROE | Market cap |
|---|---|---|
| -467.81% | $7.87M | |
| 67.11% | $7.78M | |
| -53.04% | $6.82M | |
| -56.54% | $8.44M | |
| 402.97% | $8.65M | |
| 0.12% | $7.45M | |
| 22.71% | $15.88M | |
| -367.00% | $12.59M | |
| 0% | $4.26K | |
| -61.85% | $11.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bionomics Limited's ROE?
How is the ROE calculated for Bionomics Limited (BNOEF)?
What is the highest ROE for Bionomics Limited (BNOEF)?
What is the 3-year average ROE for Bionomics Limited (BNOEF)?
What is the 5-year average ROE for Bionomics Limited (BNOEF)?
How does the current ROE for Bionomics Limited (BNOEF) compare to its historical average?